{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T05:10:40Z","timestamp":1790831440341,"version":"4.1.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lymphoma-myeloma-leukemia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lymphoma Myeloma and Leukemia"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.clml.2021.09.023","type":"journal-article","created":{"date-parts":[[2021,10,22]],"date-time":"2021-10-22T02:45:26Z","timestamp":1634870726000},"page":"e124-e127","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Hodgkin Lymphoma With Diplopia and Nystagmus: A Paraneoplastic Cerebellar Degeneration With Ectopic Expression of DNER Antigen on Reed-Sternberg Cells"],"prefix":"10.1016","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3293-986X","authenticated-orcid":false,"given":"Nicolas","family":"Fiorelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7932-8185","authenticated-orcid":false,"given":"Sara","family":"Fraticelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3258-0727","authenticated-orcid":false,"given":"Arturo","family":"Bonometti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4540-6886","authenticated-orcid":false,"given":"Luca","family":"Diamanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1221-7747","authenticated-orcid":false,"given":"Matteo","family":"Paoletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Franciotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Gotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6244-3646","authenticated-orcid":false,"given":"Marco","family":"Lucioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Paulli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Arcaini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clml.2021.09.023_bib0001","doi-asserted-by":"crossref","first-page":"3230","DOI":"10.1182\/blood-2014-03-537506","article-title":"Paraneoplastic neurological syndromes in Hodgkin and non-Hodgkin lymphomas","volume":"123","author":"Graus","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.clml.2021.09.023_bib0002","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1212\/WNL.0b013e31820d62eb","article-title":"Spectrum of paraneoplastic disease associated with lymphoma","volume":"76","author":"Briani","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.clml.2021.09.023_bib0003","doi-asserted-by":"crossref","first-page":"6","DOI":"10.4103\/0972-2327.93267","article-title":"Paraneoplastic neurologic syndrome: a practical approach","volume":"15","author":"Kannoth","year":"2012","journal-title":"Ann Indian Acad Neurol"},{"key":"10.1016\/j.clml.2021.09.023_bib0004","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1476-4598-10-33","article-title":"Small-cell lung cancer-associated autoantibodies: potential applications to cancer diagnosis, early detection, and therapy","volume":"10","author":"Kazarian","year":"2011","journal-title":"Mol Cancer"},{"key":"10.1016\/j.clml.2021.09.023_bib0005","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/s41571-019-0194-4","article-title":"Paraneoplastic neurological syndromes in the era of immune-checkpoint inhibitors","volume":"16","author":"Graus","year":"2019","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.clml.2021.09.023_bib0006","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1136\/jnnp.2003.034447","article-title":"Recommended diagnostic criteria for paraneoplastic neurological syndromes","volume":"75","author":"Graus","year":"2004","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.clml.2021.09.023_bib0007","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1053\/j.seminoncol.2006.03.008","article-title":"Paraneoplastic syndromes affecting the nervous system","volume":"33","author":"Darnell","year":"2006","journal-title":"Semin Oncol."},{"key":"10.1016\/j.clml.2021.09.023_bib0008","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1001\/archneur.1976.00500090066014","article-title":"Cerebellar degeneration with Hodgkin disease: an immunological study","volume":"33","author":"Trotter","year":"1976","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.clml.2021.09.023_bib0009","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0165-5728(96)00205-6","article-title":"Immunological characterization of a neuronal antibody (anti-Tr) associated with paraneoplastic cerebellar degeneration and Hodgkin's disease","volume":"74","author":"Graus","year":"1997","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.clml.2021.09.023_bib0010","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1093\/brain\/awg133","article-title":"Paraneoplastic cerebellar degeneration associated with antineuronal antibodies: analysis of 50 patients","volume":"126","author":"Shams'ili","year":"2003","journal-title":"Brain"},{"key":"10.1016\/j.clml.2021.09.023_bib0011","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1212\/01.WNL.0000041495.87539.98","article-title":"Anti-Tr antibodies as markers of paraneoplastic cerebellar degeneration and Hodgkin's disease","volume":"60","author":"Bernal","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.clml.2021.09.023_bib0012","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1002\/ana.23550","article-title":"Identification of delta\/notch-like epidermal growth factor-related receptor as the Tr antigen in paraneoplastic cerebellar degeneration","volume":"71","author":"De Graaff","year":"2012","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.clml.2021.09.023_bib0013","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1001\/jamaneurol.2014.999","article-title":"Antibodies to delta\/notch-like epidermal growth factor-related receptor in patients with anti-Tr, paraneoplastic cerebellar degeneration, and Hodgkin lymphoma","volume":"71","author":"Greene","year":"2014","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.clml.2021.09.023_bib0014","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1200\/JCO.2010.32.8401","article-title":"Molecular pathogenesis of hodgkin's lymphoma: Increasing evidence of the importance of the microenvironment","volume":"29","author":"Steidl","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clml.2021.09.023_bib0015","article-title":"Medusa head ataxia\u2019: The expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. Part 3: Anti-Yo\/CDR2, anti-Nb\/AP3B2, PCA-2, anti-Tr\/DNER, other antibodies, diagnostic pitfalls, summary and outlook","volume":"12","author":"Jarius","year":"2015","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.clml.2021.09.023_bib0016","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/BF03401727","article-title":"Expression of amphiphysin I, an autoantigen of paraneoplastic neurological syndromes, in breast cancer","volume":"4","author":"Floyd","year":"1998","journal-title":"Mol Med."},{"key":"10.1016\/j.clml.2021.09.023_bib0017","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1007\/s00262-017-2041-8","article-title":"Cerebellar degeneration-related proteins 2 and 2-like are present in ovarian cancer in patients with and without Yo antibodies","volume":"66","author":"Raspotnig","year":"2017","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.clml.2021.09.023_bib0018","article-title":"Medusa head ataxia\u2019: The expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. Part 2: anti-PKC-gamma, anti-GluR-delta2, anti-Ca\/ARHGAP26 and anti-VGCC","volume":"12","author":"Jarius","year":"2015","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.clml.2021.09.023_bib0019","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1186\/s12974-015-0356-y","article-title":"Medusa-head ataxia\u2019: The expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. Part 1: anti-mGluR1, anti-Homer-3, anti-Sj\/ITPR1 and anti-CARP VIII","volume":"12","author":"Jarius","year":"2015","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.clml.2021.09.023_bib0020","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1006\/scbi.2000.0327","article-title":"Interaction between host T cells and Reed-Sternberg cells in Hodgkin lymphomas","volume":"10","author":"Poppema","year":"2000","journal-title":"Semin Cancer Biol."},{"key":"10.1016\/j.clml.2021.09.023_bib0021","doi-asserted-by":"crossref","first-page":"4283","DOI":"10.1182\/blood-2002-01-0099","article-title":"The role of cytokines in classical Hodgkin lymphoma","volume":"99","author":"Skinnider","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.clml.2021.09.023_bib0022","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1007\/s00262-004-0653-2","article-title":"Tumor antigen-specific T helper cells in cancer immunity and immunotherapy","volume":"54","author":"Knutson","year":"2005","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.clml.2021.09.023_bib0023","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1158\/2326-6066.CIR-16-0201","article-title":"Classical Hodgkin lymphoma with reduced \u03b22M\/MHC class i expression is associated with inferior outcome independent of 9p24.1 status","volume":"4","author":"Roemer","year":"2016","journal-title":"Cancer Immunol Res."},{"key":"10.1016\/j.clml.2021.09.023_bib0024","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.3324\/haematol.2017.184192","article-title":"Hide or defend, the two strategies of lymphoma immune evasion: potential implications for immunotherapy","volume":"103","author":"de Charette","year":"2018","journal-title":"Haematologica"},{"key":"10.1016\/j.clml.2021.09.023_bib0025","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2017.1295202","article-title":"HLA dependent immune escape mechanisms in B-cell lymphomas: implications for immune checkpoint inhibitor therapy?","volume":"6","author":"Nijland","year":"2017","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.clml.2021.09.023_bib0026","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.1200\/JCO.2006.10.0917","article-title":"HLA class II expression by Hodgkin Reed-Sternberg cells is an independent prognostic factor in classical Hodgkin's lymphoma","volume":"25","author":"Diepstra","year":"2007","journal-title":"J Clin Oncol."}],"container-title":["Clinical Lymphoma Myeloma and Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265021024113?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265021024113?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:38:45Z","timestamp":1761871125000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2152265021024113"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["S2152265021024113"],"URL":"https:\/\/doi.org\/10.1016\/j.clml.2021.09.023","relation":{},"ISSN":["2152-2650"],"issn-type":[{"value":"2152-2650","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hodgkin Lymphoma With Diplopia and Nystagmus: A Paraneoplastic Cerebellar Degeneration With Ectopic Expression of DNER Antigen on Reed-Sternberg Cells","name":"articletitle","label":"Article Title"},{"value":"Clinical Lymphoma Myeloma and Leukemia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clml.2021.09.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}